Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $446.4 million specializing in mRNA therapeutics and vaccines, stands at a ...

The Trump administration is freezing all National Institutes of Health research grants, potentially throwing sand into a ...

Experts in every field of medical research gather at meetings to decide which topics and projects are most deserving of funds ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

CRANBURY, NEW JERSEY / ACCESS Newswire / January 28, 2025 / AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process de ...

Researchers are worried about the federal cancellation of meetings last week which are key to hundreds of millions in funding ...

Legend Biotech Corporation (NASDAQ:LEGN), with a market capitalization of $6.74 billion, has emerged as a prominent player in the biotechnology sector, primarily due to the success of its flagship ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

SCIENCE: Trudeau Institute, Ampersand Biosciences producing tools for flu research with $1M grant SARANAC LAKE — Local research and biotechnology laboratories Trudeau Institute and Ampersand ...

SINGAPORE - Media OutReach Newswire - 27 January 2025 - Dou Yee Enterprises, a prominent global player in high-tech manufacturing and precision engineering, has entered into ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

Small companies attempting to help solve a global crisis in drug-resistant infections with novel treatments are facing a wall ...